Genesco Financials
This page shows Genesco (GCO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation recovered faster than earnings because working capital released cash and debt largely disappeared.
By FY2026, operating cash flow reached$145.8M while net income was only$13M ; helped by leaner inventory and receivables, that gap shows cash conversion improved even though profitability stayed thin. That cash rebuilt cash on hand to$105.4M and cut long-term debt to just$3.4M , materially strengthening the balance sheet after the prior two-year earnings slump.
The tougher issue is not demand alone: sales have recovered to slightly above the earlier peak, but gross margin fell from
Capital intensity looks manageable rather than expansionary: annual capital spending stayed near
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Genesco's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Genesco has an operating margin of 0.7%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 36/100, indicating healthy but not exceptional operating efficiency. This is up from 0.6% the prior year.
Genesco's revenue grew a modest 4.8% year-over-year to $2.4B. This slow but positive growth earns a score of 40/100.
Genesco carries a low D/E ratio of 0.08, meaning only $0.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.
Genesco's current ratio of 1.83 indicates adequate short-term liquidity, earning a score of 53/100. The company can meet its near-term obligations, though with limited headroom.
Genesco has a free cash flow margin of 3.4%, earning a moderate score of 38/100. The company generates positive cash flow after capital investments, but with room for improvement.
Genesco's ROE of 2.4% shows moderate profitability relative to equity, earning a score of 35/100. This is up from -3.6% the prior year.
Genesco scores 2.56, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Genesco passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Genesco generates $11.21 in operating cash flow ($145.8M OCF vs $13.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Genesco earns $4.2 in operating income for every $1 of interest expense ($17.3M vs $4.1M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Genesco generated $2.4B in revenue in fiscal year 2026. This represents an increase of 4.8% from the prior year.
Genesco's EBITDA was $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.
Genesco reported $13.0M in net income in fiscal year 2026. This represents an increase of 168.4% from the prior year.
Genesco earned $1.25 per diluted share (EPS) in fiscal year 2026. This represents an increase of 171.8% from the prior year.
Cash & Balance Sheet
Genesco generated $83.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 79.0% from the prior year.
Genesco held $27.1M in cash against $45.3M in long-term debt as of fiscal year 2026.
Genesco had 11M shares outstanding in fiscal year 2026. This represents a decrease of 1.6% from the prior year.
Margins & Returns
Genesco's gross margin was 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.
Genesco's operating margin was 0.7% in fiscal year 2026, reflecting core business profitability. This is up 0.1 percentage points from the prior year.
Genesco's net profit margin was 0.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the prior year.
Genesco's ROE was 2.4% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 6.0 percentage points from the prior year.
Capital Allocation
Genesco spent $12.6M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 28.4% from the prior year.
Genesco invested $62.1M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 50.9% from the prior year.
GCO Income Statement
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $487.0M-21.0% | $616.2M+12.9% | $546.0M+15.2% | $474.0M-35.0% | $729.6M+22.3% | $596.3M+13.5% | $525.2M+14.8% | $457.6M |
| Cost of Revenue | $258.1M-21.2% | $327.6M+10.7% | $296.0M+17.1% | $252.8M-34.3% | $384.8M+23.7% | $311.1M+11.3% | $279.5M+15.8% | $241.3M |
| Gross Profit | $228.9M-20.7% | $288.6M+15.5% | $249.9M+13.0% | $221.2M-35.8% | $344.7M+20.9% | $285.3M+16.1% | $245.6M+13.6% | $216.3M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $254.4M-7.7% | $275.7M+4.3% | $264.3M+6.1% | $249.0M-17.1% | $300.6M+9.3% | $274.9M+7.8% | $255.1M+2.9% | $247.8M |
| Operating Income | -$15.4M-279.3% | $8.6M+159.4% | -$14.4M+48.7% | -$28.1M-166.8% | $42.1M+312.7% | $10.2M+199.4% | -$10.3M+68.0% | -$32.1M |
| Interest Expense | -$265K+70.0% | -$884K+39.4% | -$1.5M-9.0% | -$1.3M+75.5% | -$5.5M-550.9% | $1.2M-9.8% | $1.3M+51.1% | $890K |
| Income Tax | -$1.1M-150.6% | $2.1M-12.0% | $2.4M+128.5% | -$8.5M-174.9% | $11.3M-59.3% | $27.8M+1663.0% | -$1.8M+79.9% | -$8.8M |
| Net Income | -$14.8M-376.6% | $5.4M+129.0% | -$18.5M+13.0% | -$21.2M-168.1% | $31.2M+264.5% | -$18.9M-89.5% | -$10.0M+59.0% | -$24.3M |
| EPS (Diluted) | $-1.42-384.0% | $0.50+127.9% | $-1.79+11.4% | $-2.02 | N/A | $-1.76-93.4% | $-0.91+59.2% | $-2.23 |
GCO Balance Sheet
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B-6.0% | $1.5B+3.5% | $1.4B+1.2% | $1.4B+5.2% | $1.3B-7.0% | $1.4B+3.7% | $1.4B+5.8% | $1.3B |
| Current Assets | $595.8M-13.5% | $689.1M+6.7% | $645.9M+2.0% | $633.3M+4.0% | $608.8M-7.7% | $659.7M+8.7% | $606.7M+19.4% | $508.0M |
| Cash & Equivalents | $27.1M+0.3% | $27.0M-34.0% | $41.0M+88.5% | $21.7M-36.0% | $34.0M+1.3% | $33.6M-26.8% | $45.9M+138.2% | $19.2M |
| Inventory | $476.9M-14.6% | $558.1M+11.4% | $501.0M+11.1% | $450.8M+6.0% | $425.2M-18.7% | $523.2M+16.2% | $450.2M+14.6% | $392.7M |
| Accounts Receivable | $47.7M-14.6% | $55.8M+2.8% | $54.3M+2.9% | $52.8M+8.1% | $48.9M-6.7% | $52.4M-8.9% | $57.5M+14.7% | $50.1M |
| Goodwill | $9.5M+3.3% | $9.2M0.0% | $9.2M-1.5% | $9.3M+5.1% | $8.9M-4.0% | $9.2M-0.6% | $9.3M-1.4% | $9.4M |
| Total Liabilities | $831.6M-13.2% | $958.3M+4.7% | $915.6M+3.8% | $882.4M+11.9% | $788.6M-14.2% | $918.6M+7.9% | $851.1M+12.1% | $759.0M |
| Current Liabilities | $324.9M-25.5% | $436.0M+5.2% | $414.4M+25.2% | $330.9M-12.9% | $379.8M-10.0% | $422.1M+6.7% | $395.7M+28.4% | $308.2M |
| Long-Term Debt | $45.3M-35.0% | $69.8M+21.0% | $57.7M-49.3% | $113.7M | $0-100.0% | $100.1M+28.6% | $77.8M+30.9% | $59.4M |
| Total Equity | $552.4M+7.5% | $513.8M+1.5% | $506.4M-3.0% | $522.2M-4.5% | $547.0M+5.8% | $516.9M-3.0% | $532.6M-2.9% | $548.5M |
| Retained Earnings | $248.9M+14.0% | $218.3M+2.5% | $213.0M-8.2% | $232.0M-12.7% | $265.9M+14.6% | $232.0M-7.7% | $251.4M-7.5% | $271.6M |
GCO Cash Flow Statement
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$102.8M-696.4% | -$12.9M-114.9% | $86.3M+185.5% | -$101.0M-186.4% | $117.0M+606.9% | -$23.1M-183.3% | $27.7M+182.1% | -$33.7M |
| Capital Expenditures | $15.4M-17.1% | $18.6M+26.7% | $14.7M-22.3% | $18.9M+37.6% | $13.7M+4.7% | $13.1M+66.2% | $7.9M+23.8% | $6.4M |
| Free Cash Flow | -$118.2M-275.1% | -$31.5M-144.0% | $71.7M+159.8% | -$119.9M-216.1% | $103.3M+385.2% | -$36.2M-282.7% | $19.8M+149.4% | -$40.1M |
| Investing Cash Flow | -$15.4M+17.1% | -$18.6M-26.7% | -$14.7M+22.3% | -$18.9M-37.6% | -$13.7M-4.7% | -$13.1M-66.2% | -$7.9M-23.8% | -$6.4M |
| Financing Cash Flow | $40.0M+128.0% | $17.5M+133.5% | -$52.4M-148.9% | $107.3M+205.7% | -$101.5M-529.9% | $23.6M+253.6% | $6.7M-72.4% | $24.2M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | $0 | $0-100.0% | $12.6M | $0-100.0% | $440K-95.3% | $9.3M | $0 |
GCO Financial Ratios
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.0%+0.2pp | 46.8%+1.1pp | 45.8%-0.9pp | 46.7%-0.6pp | 47.3%-0.6pp | 47.8%+1.1pp | 46.8%-0.5pp | 47.3% |
| Operating Margin | -3.2%-4.5pp | 1.4%+4.0pp | -2.6%+3.3pp | -5.9%-11.7pp | 5.8%+4.1pp | 1.7%+3.7pp | -2.0%+5.1pp | -7.0% |
| Net Margin | -3.0%-3.9pp | 0.9%+4.3pp | -3.4%+1.1pp | -4.5%-8.8pp | 4.3%+7.4pp | -3.2%-1.3pp | -1.9%+3.4pp | -5.3% |
| Return on Equity | -2.7%-3.7pp | 1.0%+4.7pp | -3.6%+0.4pp | -4.1%-9.8pp | 5.7%+9.4pp | -3.7%-1.8pp | -1.9%+2.6pp | -4.4% |
| Return on Assets | -1.1%-1.4pp | 0.4%+1.7pp | -1.3%+0.2pp | -1.5%-3.8pp | 2.3%+3.7pp | -1.3%-0.6pp | -0.7%+1.1pp | -1.9% |
| Current Ratio | 1.83+0.3 | 1.58+0.0 | 1.56-0.4 | 1.91+0.3 | 1.60+0.0 | 1.56+0.0 | 1.53-0.1 | 1.65 |
| Debt-to-Equity | 0.08-0.1 | 0.14+0.0 | 0.11-0.1 | 0.22+0.2 | 0.00-0.2 | 0.19+0.0 | 0.15+0.0 | 0.11 |
| FCF Margin | -24.3%-19.2pp | -5.1%-18.2pp | 13.1%+38.4pp | -25.3%-39.4pp | 14.1%+20.2pp | -6.1%-9.8pp | 3.8%+12.5pp | -8.8% |
Similar Companies
Frequently Asked Questions
What is Genesco's annual revenue?
Genesco (GCO) reported $2.4B in total revenue for fiscal year 2026. This represents a 4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Genesco's revenue growing?
Genesco (GCO) revenue grew by 4.8% year-over-year, from $2.3B to $2.4B in fiscal year 2026.
Is Genesco profitable?
Yes, Genesco (GCO) reported a net income of $13.0M in fiscal year 2026, with a net profit margin of 0.5%.
What is Genesco's EBITDA?
Genesco (GCO) had EBITDA of $70.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Genesco have?
As of fiscal year 2026, Genesco (GCO) had $27.1M in cash and equivalents against $45.3M in long-term debt.
What is Genesco's gross margin?
Genesco (GCO) had a gross margin of 46.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Genesco's operating margin?
Genesco (GCO) had an operating margin of 0.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Genesco's net profit margin?
Genesco (GCO) had a net profit margin of 0.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Genesco's return on equity (ROE)?
Genesco (GCO) has a return on equity of 2.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Genesco's free cash flow?
Genesco (GCO) generated $83.7M in free cash flow during fiscal year 2026. This represents a 79.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Genesco's operating cash flow?
Genesco (GCO) generated $145.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Genesco's total assets?
Genesco (GCO) had $1.4B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Genesco's capital expenditures?
Genesco (GCO) invested $62.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Genesco's current ratio?
Genesco (GCO) had a current ratio of 1.83 as of fiscal year 2026, which is generally considered healthy.
What is Genesco's debt-to-equity ratio?
Genesco (GCO) had a debt-to-equity ratio of 0.08 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Genesco's return on assets (ROA)?
Genesco (GCO) had a return on assets of 0.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Genesco's Altman Z-Score?
Genesco (GCO) has an Altman Z-Score of 2.56, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Genesco's Piotroski F-Score?
Genesco (GCO) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Genesco's earnings high quality?
Genesco (GCO) has an earnings quality ratio of 11.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Genesco cover its interest payments?
Genesco (GCO) has an interest coverage ratio of 4.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Genesco?
Genesco (GCO) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.